From March 9-12, 2013 top women’s cancer doctors from all over the world met in Los Angeles for the Society of Gynecologic Oncology‘s Annual Meeting on Women’s Cancer. Lots of exciting … Continued
Two studies recently released show a survival benefit for intraperitoneal IP chemotherapy Women with the BRCA1 mutation given IP chemotherapy survived three years longer than those given IV chemotherapy. Read … Continued
The New York Times reported today on a study that found most women with ovarian cancer receive inadequate care. The article discusses research presented at the 2013 meeting of the … Continued
Calaneet Balas, OCNA’s Chief Executive Officer, testified before the House Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on Wednesday, March 13. Her remarks touched on the … Continued
Often, patients enrolled in clinical trials live longer than those who are not, however, a new study shows that the survival benefit may be due to the patient’s health, not … Continued
For immediate release: February 28, 2013 Washington, DC—The federal government recently released regulations that clarify which preventive services will be covered under the Affordable Care Act without cost sharing for … Continued
Michele Robinson came up with the idea for her cancer support group, “You’ll Never Walk Alone,” during her first chemotherapy treatment for ovarian cancer in November 2004. “I was looking … Continued
New research published in Human Reproduction Update provides additional evidence that in vitro fertilization (IVF) does not increase women’s risk for ovarian, endometrial, and cervical cancer. Researchers have wondered if fertility treatments … Continued
In a report issued this month, the American Cancer Society released new statistics on cancer in African Americans. Overall, cancer death rates among both African American men and women have … Continued
A study of the medical records of more than 67,000 women who underwent fertility treatment found that fertility treatments did not effect the risk of breast or uterine cancer, and … Continued
A new study published in Endocrine-Related Cancer which used data from the OCRF-funded Ovarian Cancer Association Consortium, evaluated the association between BMI and ovarian cancer risk, and also examined the association by … Continued
The University of Texas MD Anderson Cancer Center is one of the nation’s preeminent hospitals for cancer care. Located in Houston, Texas, MD Anderson’s Blanton-Davis Ovarian Cancer Research Program was … Continued
Get email updates about research news, action alerts, and ways to join the fight.
